An open label study of gabapentin in the treatment of acute mania

Journal of Psychiatric Research

Volumn 32, Issue 5, 1998, Pages 261-264

  Erfurth, Andreas ^a   Kammerer, Christine ^a   Grunze, Heinz ^a   Normann, Claus ^b   Walden, Jörg ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; GABAPENTIN; LITHIUM; VALPROIC ACID;

ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; MANIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TIME; TREATMENT OUTCOME;

ACETIC ACIDS; ACUTE DISEASE; AMINES; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; GAMMA-AMINOBUTYRIC ACID; HUMANS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 0032168304     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(98)00010-7     Document Type: Article

References (25)

1. Ballenger JC, Post RM Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiat 1980;137:782-90.
2. Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E. Progress report on new antiepileptic drugs: a summary of the third Eilat conference. Epilepsy Res 1996;25:299-319.
3. Bech P, Rafaelsen OJ, Kramp P, Bolwig TG. The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 1978;17:430-1.
4. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, Dilsaver SC, Davis JM, Rush AJ, Small JG, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 1994;271:918-24.
5. Bowden CL. Role of newer medications for bipolar disorder, J Clin Psychopharmacol 1996;16:48S-55S.
6. Bruni J. Gabapentin. Can J Neurol Sci 1996;23:10-12.
7. Calabrese JR, Fatemi SH, Kujawa M, Woyshville MJ. Predictors of response to mood stabilizers. J of Clin Psychopharmacology 1996;16(Suppl. 1):24S-31S.
8. Chadwick DW. An overview of the efficacy and tolerability of new antiepileptic drugs. Epilepsia 1997;38(Suppl. 1): S59-S62.
9. Dichter MA, Brodie J. New antiepileptic drugs. The New England Journal of Medicine 1996;334:1583-90.
10. Gee NS, Brown JP, Dissanayake VU, Offord J, Thurlow R, Woodruff GN. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J Biol Chem 1996; 271:5768-76.
11. Keck PE Jr, McElroy SL, Tugrul KC, Bennett JA. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993;54:305-8.
12. McElroy SL, Soutullo CA, Keck PE Jr, Kmetz GF. A pilot trial of adjunctive gabapentin in the treatment of bipolar disorder. Ann Clin Psych 1997;9:99-103.
13. Meldrum BS. Update on the mechanism of action of antiepileptic drugs. Epilepsia 1997;37(Suppl. 6):S4-S11.
14. Okuma T, Kishimoto A, Inoue K, Matsumoto H, Ogura A, Matsishita T, Nakao T, Ogura C. Antimanic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis: A preliminary report. Folia Psychiatr Neurol Japonica 1973;27:283-97.
15. Pope HG Jr, McElroy SL, Keck PE Jr, Hudson JI. Valproate in the treatment of acute mania. A placebo-controlled study. Arch Gen Psychiatry 1991;48:62-8.
16. Riva R, Albani F, Contin M, Baruzzi A. Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations. Clin Pharmacokinet 1996;31:470-93.
17. Ryback R, Ryback L. Gabapentin for behavioral dyscontrol. Am J Psychiatry 1995;152:1399.
18. Schaffer CB, Scharfer LC. Gabapentin in the treatment of bipolar disorder. Am J Psychiatry 1997;154:291-2.
19. Short C, Cooke L. Hypomania induced by gabapentin. Br J Psychiatry 1995;166:679-80.
20. Stanton SP, Keck PE, McElroy SL. Treatment of acute mania with gabapentin. Am J Psychiatry 1997;154:287.
21. Tallian KB, Nahata MC, Lo W, Tsao CY. Gabapentin associated with aggressive behavior in pediatric patients with seizures. Epilepsia 1996;37:501-2.
22. 3H]-gabapentin with excitatory amino acid receptor and amino acid uptake site distribution in rat brain. Br J Pharmacol 1996;118:457-65.
23. Walden J, Hesslinger B. Value of old and new anticonvulsants in treatment of psychiatric disease. Fortschr Neurol Psychiatr 1995;63:320-35.
24. Walden J, Hesslinger B, van Calker D, Berger M. Addition of lamotrigine to valproate may enhance efficacy in the treatment of bipolar disorder. Pharmacopsychiatry 1996;29:193-95.
25. Wolf S, Shinnar S, Kang H, Gil K, Moshe S. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 1996;36:1203-5.